Immunomodulation by Zwitterionic Polysaccharides

Microbial Glycobiology

Volumn , Issue , 2010, Pages 957-980

  McLoughlin, Rachel M ^a   Kasper, Dennis L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882899110     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374546-0.00049-3     Document Type: Chapter

References (79)

1. Alexander C., Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 2001, 7:167-202.
2. Alm J.S., Swartz J., Bjorksten B., et al. An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr. Allergy Immunol. 2002, 13:402-411.
3. Bamias G., Cominelli F. Immunopathogenesis of inflammatory bowel disease: current concepts. Curr. Opin. Gastroenterol. 2007, 23:365-369.
4. Barrett D.J. Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Adv. Pediatr. 1985, 32:139-158.
5. Bartlett J.C. Antimicrobial therapy in experimental intra-abdominal sepsis. J. Antimicrob. Chemother. 1978, 4:392-394.
6. Baumann H., Tzianabos A.O., Brisson J.R., Kasper D.L., Jennings H.J. Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. Biochemistry 1992, 31:4081-4089.
7. Bergenholt S. Cells and cytokines in the pathogenesis of inflammatory bowel disease: new insights from mouse T-cell transfer models. Exp. Clin. Immunogenet. 2000, 17:115-129.
8. Bjorksten B. The environmental influence on childhood asthma. Allergy 1999, 54(Suppl. 49):17-23.
9. Bowdish D.M., Davidson D.J., Lau Y.E., Lee K., Scott M.G., Hancock R.E. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 2005, 77:451-459.
10. Carpenter S., O'Neill L.A. How important are Toll-like receptors for antimicrobial responses?. Cell Microbiol. 2007, 9:1891-1901.
11. Chegini N. Peritoneal molecular environment, adhesion formation and clinical implication. Front. Biosci. 2002, 7:e91-115.
12. Choi Y.H., Roehrl M.H., Kasper D.L., Wang J.Y. A unique structural pattern shared by T-cell-activating and abscess-regulating zwitterionic polysaccharides. Biochemistry 2002, 41:15144-15151.
13. + T-cells regulate surgical and postinfectious adhesion formation. J. Exp. Med. 2002, 195:1471-1478.
14. + T-cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J. Immunol. 2003, 170:1958-1963.
15. Cobb B.A., Kasper D.L. Zwitterionic capsular polysaccharides: the new MHC II-dependent antigens. Cell Microbiol. 2005, 7:1398-1403.
16. Cobb B.A., Wang Q., Tzianabos A.O., Kasper D.L. Polysaccharide processing and presentation by the MHC II pathway. Cell 2004, 117:677-687.
17. Coutinho A., Moller G., Anderson J., Bullock W.W. In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B-cell mitogens on proliferation and antibody synthesis. Eur. J. Immunol. 1973, 3:299-306.
18. + T-cells with a naïve phenotype in the periphery. Dev. Immunol. 1992, 2:141-150.
19. Duan J., Avci F.Y., Kasper D.L. Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. Proc. Natl. Acad. Sci. USA 2008, 105:5183-5188.
20. Ellis H. The clinical significance of adhesions: focus on intestinal obstruction. Eur. J. Surg. Suppl. 1997, 5-9.
21. Erridge C., Pridmore A., Eley A., Stewart J., Poxton I.R. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J. Med. Microbiol. 2004, 53:735-740.
22. Falk PG., Hooper L.V., Midtvedt T., Gordon J.I. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 1998, 62:1157-1170.
23. Finlay B.B., Hancock R.E. Can innate immunity be enhanced to treat microbial infections?. Nat. Rev. Microbiol. 2004, 2:497-504.
24. Forman H.J., Torres M. Redox signaling in macrophages. Mol. Aspects Med. 2001, 22:189-216.
25. Gallorini S., Berti F., Parente P., et al. Introduction of zwitterionic motifs into bacterial polysaccharides generates TLR2 agonists able to activate APCs. J. Immunol. 2007, 179:8208-8215.
26. + T-cell survival. J. Immunol. 2004, 172:6065-6073.
27. Gill S.R., Pop M., Deboy R.T., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
28. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
29. Gutcher I., Becher B. APC-derived cytokines and T-cell polarization in autoimmune inflammation. J. Clin. Invest. 2007, 117:1119-1127.
30. Hoebe K., Janssen E., Beutler B. The interface between innate and adaptive immunity. Nat. Immunol. 2004, 5:971-974.
31. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
32. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
33. Janeway C.A, Travers P., Walport M., Shlomchik M. Immunobiology 2005, Garland Science Publishing, London. 6th edn.
34. Kalka-Moll W.M., Tzianabos A.O., Bryant P.W., Niemeyer M., Ploegh H.L., Kasper D.L. Zwitterionic polysaccharides stimulate T-cells by MHC class II-dependent interactions. J. Immunol. 2002, 169:6149-6153.
35. Kasper D.L., Onderdonk A.B., Crabb J., Bartlett J.G. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J. Infect. Dis. 1979, 140:724-731.
36. Kelly D.F., Moxon E.R., Pollard A.J. Haemophilus influenzae type b conjugate vaccines. Immunology 2004, 113:163-174.
37. Krinos C.M., Coyne M.J., Weinacht K.G., Tzianabos A.O., Kasper D.L., Comstock L.E. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 2001, 414:555-558.
38. Kronenberg M., Siu G., Hood L.E., Shastri N. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu. Rev. Immunol. 1986, 4:529-591.
39. Kuwahara T., Yamashita A., Hirakawa H., et al. Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc. Natl. Acad. Sci. USA 2004, 101:14919-14924.
40. Lindberg B., Lindqvist B., Lonngren J., Powell D.A. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 1. Carbohydr. Res. 1980, 78:111-117.
41. Lindberg A.A., Weintraub A., Kasper D.L., Lonngren J. Virulence factors in infections with Bacteroides fragilis: isolation and characterization of capsular polysaccharide and lipopolysaccharide. Scand. J. Infect. Dis. Suppl. 1982, 35:45-52.
42. Mazmanian S.K., Kasper D.L. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 2006, 6:849-858.
43. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
44. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:602-604.
45. McCormack P.L., Scott L.J. Interferon-β-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis. CNS Drugs 2004, 18:521-546.
46. McGhee J.R., Michalek S.M., Kiyono H., et al. Mucosal immunoregulation: environmental lipopolysaccharide and GALT T lymphocytes regulate the IgA response. Microbiol. Immunol. 1984, 28:261-280.
47. McLoughlin R.M., Lee J.C., Kasper D.L., Tzianabos A.O. IFN-γ regulated chemokine production determines the outcome of Staphylococcus aureus infection. J. Immunol. 2008, 181:1323-1332.
48. Miller S.I., Ernst R.K., Bader M.W. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 2005, 3:36-46.
49. Onderdonk A.B., Kasper D.L., Cisneros R.L., Bartlett J.G. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J. Infect. Dis. 1977, 136:82-89.
50. Pasare C., Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 2004, 6:1382-1387.
51. Plosker G.L., Figgitt D.P. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 2003, 63:803-843.
52. Poxton I.R., Brown R., Sawyerr A., Ferguson A. Mucosa-associated bacterial flora of the human colon. J. Med. Microbiol. 1997, 46:85-91.
53. Robinson D.S., O'Garra A. Further checkpoints in Th1 development. Immunity 2002, 16:755-758.
54. Ruiz-Perez B., Chung D.R., Sharpe A.H., et al. Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc. Natl. Acad. Sci. USA 2005, 102:16753-16758.
55. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:390-407.
56. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75:163-189.
57. Scott M.G., Dullaghan E., Mookherjee N., et al. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 2007, 25:465-472.
58. Silver R.P., Aaronson W., Vann W.F. The K1 capsular polysaccharide of Escherichia coli. Rev. Infect. Dis. 1988, 10:S282-286.
59. Sood R.K., Fattom A. Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins. Expert Opin. Investig. Drugs 1998, 7:333-347.
60. Stephen T.L., Niemeyer M., Tzianabos A.O., Kroenke M., Kasper D.L., Kalka-Moll W.M. Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation. Infect. Immun. 2005, 73:2184-2189.
61. Stingele F., Corthesy B., Kusy N., Porcelli S.A., Kasper D.L., Tzianabos A.O. Zwitterionic polysaccharides stimulate T-cells with no preferential Vβ usage and promote anergy, resulting in protection against experimental abscess formation. J. Immunol. 2004, 172:1483-1490.
62. Stock P., Akbari O., Berry G., Freeman G.J., Dekruyff R.H., Umetsu D.T. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 2004, 5:1149-1156.
63. Strachan D.P. Hay fever, hygiene, and household size. Br. Med. J. 1989, 299:1259-1260.
64. Szu S.C., Li X.R., Stone A.L., Robbins J.B. Relation between structure and immunologic properties of the Vi capsular polysaccharide. Infect. Immun. 1991, 59:4555-4561.
65. Takeda K., Akira S. TLR signalling pathways. Semin. Immunol. 2004, 16:3-9.
66. Tzianabos A.O., Kasper D.L. Role of T-cells in abscess formation. Curr. Opin. Microbiol. 2002, 5:92-96.
67. Tzianabos A.O., Onderdonk A.B., Rosner B., Cisneros R.L., Kasper D.L. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 1993, 262:416-419.
68. Tzianabos A.O., Onderdonk A.B., Smith R.S., Kasper D.L. Structure-function relationships for polysaccharide-induced intra-abdominal abscesses. Infect. Immun. 1994, 62:3590-3593.
69. Tzianabos A.O., Kasper D.L., Cisneros R.L., Smith R.S., Onderdonk A.B. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J. Clin. Invest. 1995, 96:2727-3271.
70. Tzianabos A.O., Finberg R.W., Wang Y., et al. T-cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J. Biol. Chem. 2000, 275:6733-6740.
71. Tzianabos A.O., Wang J.Y., Lee J.C. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc. Natl. Acad. Sci. USA 2001, 98:9365-9370.
72. Tzianabos A., Wang J.Y., Kasper D.L. Biological chemistry of immunomodulation by zwitterionic polysaccharides. Carbohydr. Res. 2003, 338:2531-2538.
73. Umetsu D.T., Dekruyff R.H. Immune dysregulation in asthma. Curr. Opin. Immunol. 2006, 18:727-732.
74. Wang Q., McLoughlin R.M., Cobb B.A., et al. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J. Exp. Med. 2006, 203:2853-2863.
75. Wang Y., Kalka-Moll W.M., Roehrl M.H., Kasper D.L. Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis. Proc. Natl. Acad. Sci. USA 2000, 97:13478-13483.
76. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 1997, 15:821-850.
77. Wessels M.R., DiFabio J.L., Benedi V., et al. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide. J. Biol. Chem. 1991, 266:6714-6719.
78. Wills-Karp M., Santeliz J., Karp C.L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 2001, 1:69-75.
79. Yoon J.W., Jun H.S. Autoimmune destruction of pancreatic β cells. Am. J. Ther. 2005, 12:580-591.